Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu (Q40681120)
scientific article published on September 1995
Language:
Current Data About Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
(P31) (Q13442814)
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P304) 2281-2292
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P407) (Q1860)

(P433) 9
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P478) 13
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P577) Friday, September 1, 1995
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P921) (Q172341)
(P887)

(P1433) (Q400292)
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P1476) "Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu" (language: en)
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

(P2093) F H Valone
(P1545) 1
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

P A Kaufman
(P1545) 2
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

P M Guyre
(P1545) 3
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

L D Lewis
(P1545) 4
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

V Memoli
(P1545) 5
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

Y Deo
(P1545) 6
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

R Graziano
(P1545) 7
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

J L Fisher
(P1545) 8
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

L Meyer
(P1545) 9
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

M Mrozek-Orlowski
(P1545) 10
(P248)
(P698) 7545221
(P813) Friday, September 22, 2017

other details
description scientific article published on September 1995

External Links
(P356) 10.1200/JCO.1995.13.9.2281
(P698) 7545221